These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1562996)

  • 1. Application of molecular genetics to the early diagnosis and screening of lung cancer.
    Birrer MJ; Brown PH
    Cancer Res; 1992 May; 52(9 Suppl):2658s-2664s. PubMed ID: 1562996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of lung cancer.
    Wistuba II; Gazdar AF
    Verh Dtsch Ges Pathol; 2000; 84():96-105. PubMed ID: 11217455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
    J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular biology of lung cancer: application to early detection and prevention.
    Sabichi AL; Birrer MJ
    Oncology (Williston Park); 1993 Jun; 7(6):19-26; discussion 31-2, 37. PubMed ID: 8318356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of molecular diagnosis to human lung cancer].
    Isobe T
    Rinsho Byori; 1995 Aug; 43(8):792-8. PubMed ID: 7474438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking molecular damage in bronchial epithelium.
    Wistuba II; Mao L; Gazdar AF
    Oncogene; 2002 Oct; 21(48):7298-306. PubMed ID: 12379874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
    Osada H; Takahashi T
    Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine tumors of the lung. Pathology and molecular biology.
    Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
    Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic and molecular aspects of lung cancer.
    Panani AD; Roussos C
    Cancer Lett; 2006 Jul; 239(1):1-9. PubMed ID: 16112428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
    Herzog CR; Lubet RA; You M
    J Cell Biochem Suppl; 1997; 28-29():49-63. PubMed ID: 9589349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular approach to lung cancer].
    Takahashi T; Ueda R; Takahashi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():29-32. PubMed ID: 8752479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormalities of molecular biology in premalignant lung lesions].
    Shao SJ; Wang Y; Yang PM
    Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of lung cancer and potential translational applications.
    Minna JD; Fong K; Zöchbauer-Müller S; Gazdar AF
    Cancer J; 2002; 8 Suppl 1():S41-6. PubMed ID: 12075701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early detection of occult lung cancer.
    Tockman MS; Mulshine JL
    Chest Surg Clin N Am; 2000 Nov; 10(4):737-49. PubMed ID: 11091923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular cytopathology of lung cancer--prevalence of genetic alterations and their role in the development of molecular biomarkers].
    Grote HJ; Schmiemann V; Böcking A
    Verh Dtsch Ges Pathol; 2003; 87():142-9. PubMed ID: 16888906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating DNA and lung cancer.
    Xue X; Zhu YM; Woll PJ
    Ann N Y Acad Sci; 2006 Sep; 1075():154-64. PubMed ID: 17108206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T; Takahashi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.
    Massion PP; Carbone DP
    Respir Res; 2003; 4(1):12. PubMed ID: 14641911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.